Y Takimoto

461 citations
48 papers · 355 indexed · h-index 11
Topics
Chronic Myeloid Leukemia Treatments (9 papers)Chronic Lymphocytic Leukemia Research (7 papers)Lymphoma Diagnosis and Treatment (7 papers)

In The Last Decade

Y Takimoto

47 papers receiving 352 citations

Peers

Y Takimoto
Comparison fields: 5 of 67
  • Molecular Biology 157
  • Hematology 97
  • Oncology 68
  • Pathology and Forensic Medicine 53
  • Pulmonary and Respiratory Medicine 52
Replace Naxin Guo with:
Naxin Guo United States
Wolfgang Peter Germany
Rosalia de Necochea-Campion United States
Dorota Jeziorowska France
Jana Procházková Czechia
Mari Higashiyama Japan
X Chen China
Mary Gleeson United Kingdom
Frank El Ouriaghli United States
Zsuzsanna Baka Hungary
Y Takimoto relative to Naxin Guo United States Naxin Guo's profile →
Citations per field
00.5×6.5×
Naxin Guo · 1×
Citations per year

Countries citing papers authored by Y Takimoto

Since Specialization
Citations

This map shows the geographic impact of Y Takimoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Y Takimoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Y Takimoto more than expected).

Fields of papers citing papers by Y Takimoto

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Y Takimoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Y Takimoto. The network helps show where Y Takimoto may publish in the future.

Co-authorship network of co-authors of Y Takimoto

This figure shows the co-authorship network connecting the top 25 collaborators of Y Takimoto. A scholar is included among the top collaborators of Y Takimoto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Y Takimoto. Y Takimoto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 31
2 30
3 8
4
[Chronic myelogenous leukemia following therapy for pineal germinoma].
2
5 3
6 28
7 0
8 28
9
Type 2B Hiroshima: a variant of von Willebrand disease characterized by chronic thrombocytopenia and the presence of all von Willebrand factor multimers in plasma.
8
10 11
11 10
12
[Immunological effect of recombinant interferon-gamma on tumor infiltrating lymphocytes of renal cell carcinoma--relationship with clinical stage].
5
13 5
14 8
15 1
16
[Clinical trial of inhalant recombinant interferon-gamma in patients with pulmonary metastasis from renal tumor (preliminary report)].
1
17 8
18 3
19 50
20
[Investigation of intracavernous injection of papaverine for erectile impotence].
1

About Y Takimoto

Y Takimoto is a scholar working on Hematology, Genetics and Rheumatology, having authored 48 papers that have together received 355 indexed citations. Recurring topics across this work include Chronic Myeloid Leukemia Treatments (9 papers), Chronic Lymphocytic Leukemia Research (7 papers) and Lymphoma Diagnosis and Treatment (7 papers). The work is most often cited by research in Hematology (97 citations), Genetics (45 citations) and Rehabilitation (25 citations). Y Takimoto has collaborated with scholars based in Japan, Greece and United Kingdom. Frequent co-authors include Atsushi Kuramoto, Thomas F. Deuel, Akiro Kimura, Akira Sakai, Hideki Asaoku, Yuta Katayama, Naomi Sasaki, Nobuo Oguma, Hideo Tanaka and Kôji Nanba. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and Biochemical and Biophysical Research Communications.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026